TOIIW

Oncology Institute, Inc.

Nasdaq · Services-Offices & Clinics of Doctors of Medicine · Inc. DE · CIK 0001799191
$0.0550 0.00% $4.8M
Vol
Market Cap$4.8M
Cap SizeNano Cap
Inst. Holders6 funds
Inst. Value$96.4K
Inst. Activity1 buys / 0 sells
SEC Reports1
Exchange Nasdaq·Sector Services-Offices & Clinics of Doctors of Medicine·Inc. DE·CIK 0001799191·Prev Close $0.0550

Recent Activity

May 22, 2026 SEC
Oncology Institute discloses that its third-party software vendor notified the company on May 20, 2026 that patient data
8-K — Impact 5/10
Inst.
WOLVERINE ASSET MANAGEMENT LLC — DOUBLED
191,565 shares ($9.8K)
Inst.
Walleye Capital LLC — NEAR_EXIT
53,902 shares ($280.00)
Apr 27, 2026 earnings
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
<p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASD

Top Institutional Holders

FundValueMove
LMR Partners LLP$71.0K
TORONTO DOMINION BANK$8.3K
WOLVERINE ASSET MANAGEMENT LLC$8.1KDOUBLED
HEALTHCARE OF ONTARIO PENSION$4.9K
DEUTSCHE BANK AG\$3.9K
6 institutional holders with $96.4K total value (2,188,295 shares) as of 2026-Q1. Top holders: LMR, TORONTO, WOLVERINE.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1LMR Partners LLP1,624,856$71.0K73.7%
2TORONTO DOMINION BANK187,674$8.3K8.6%
3WOLVERINE ASSET MANAGEMENT LLC185,437$8.1K8.4%DOUBLED +164.9%
4HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND87,500$4.9K5.0%
5DEUTSCHE BANK AG\96,600$3.9K4.0%
6Clear Street Group Inc.6,228$273.000.3%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
WOLVERINE ASSET MANAGEMENT LLCDOUBLED72,316191,565+164.9%$9.8K2025-Q2
Walleye Capital LLCNEAR_EXIT393,54553,902-86.3%$280.002024-Q4
UBS Group AGTRIM6,0833,106-48.9%$16.002024-Q4
BANK OF AMERICA CORP /DE/TRIM499200-59.9%$1.002024-Q4
BANK OF AMERICA CORP /DE/TRIM899499-44.5%$10.002024-Q3

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 5.0/10.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.00 $0.00 $0.00 $0.2B 31.1%
Next Q
2026-09-30
$0.00 $0.00 $0.00 $0.2B 24.1%
Current FY
2026-12-31
$0.00 $0.00 $0.00 $0.7B 31.1%
Next FY
2027-12-31
$0.00 $0.00 $0.00 $0.8B 24.5%

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Apr 27, 2026
earnings
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
<p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncolo
Apr 6, 2026
other
The Oncology Institute Names Minh Merchant Chief Legal Officer
<p>CERRITOS, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology
Mar 12, 2026
earnings
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026
<p align="left">CERRITOS, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the